nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Methotrexate—ankylosing spondylitis	0.257	0.299	CbGbCtD
Tenofovir—ABCC2—Sulfasalazine—ankylosing spondylitis	0.183	0.213	CbGbCtD
Tenofovir—ABCC4—Methotrexate—ankylosing spondylitis	0.123	0.144	CbGbCtD
Tenofovir—ABCC2—Dexamethasone—ankylosing spondylitis	0.0914	0.106	CbGbCtD
Tenofovir—SLC22A8—Methotrexate—ankylosing spondylitis	0.0771	0.0898	CbGbCtD
Tenofovir—ABCC2—Methotrexate—ankylosing spondylitis	0.0734	0.0855	CbGbCtD
Tenofovir—SLC22A6—Methotrexate—ankylosing spondylitis	0.0537	0.0625	CbGbCtD
Tenofovir—Multiple fractures—Methylprednisolone—ankylosing spondylitis	0.00215	0.016	CcSEcCtD
Tenofovir—Fracture—Methylprednisolone—ankylosing spondylitis	0.00215	0.016	CcSEcCtD
Tenofovir—Multiple fractures—Dexamethasone—ankylosing spondylitis	0.00196	0.0146	CcSEcCtD
Tenofovir—Fracture—Betamethasone—ankylosing spondylitis	0.00196	0.0146	CcSEcCtD
Tenofovir—Multiple fractures—Betamethasone—ankylosing spondylitis	0.00196	0.0146	CcSEcCtD
Tenofovir—Fracture—Dexamethasone—ankylosing spondylitis	0.00196	0.0146	CcSEcCtD
Tenofovir—Myopathy—Prednisolone—ankylosing spondylitis	0.00194	0.0145	CcSEcCtD
Tenofovir—Hepatomegaly—Prednisolone—ankylosing spondylitis	0.00192	0.0143	CcSEcCtD
Tenofovir—Myopathy—Triamcinolone—ankylosing spondylitis	0.00179	0.0133	CcSEcCtD
Tenofovir—Myopathy—Methylprednisolone—ankylosing spondylitis	0.00178	0.0133	CcSEcCtD
Tenofovir—Hepatomegaly—Triamcinolone—ankylosing spondylitis	0.00177	0.0132	CcSEcCtD
Tenofovir—Hepatomegaly—Methylprednisolone—ankylosing spondylitis	0.00177	0.0131	CcSEcCtD
Tenofovir—Fracture—Prednisone—ankylosing spondylitis	0.0017	0.0127	CcSEcCtD
Tenofovir—Multiple fractures—Prednisone—ankylosing spondylitis	0.0017	0.0127	CcSEcCtD
Tenofovir—NME1—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.00162	0.254	CbGdCrCtD
Tenofovir—Myopathy—Dexamethasone—ankylosing spondylitis	0.00162	0.0121	CcSEcCtD
Tenofovir—Myopathy—Betamethasone—ankylosing spondylitis	0.00162	0.0121	CcSEcCtD
Tenofovir—Hepatomegaly—Betamethasone—ankylosing spondylitis	0.00161	0.0119	CcSEcCtD
Tenofovir—Hepatomegaly—Dexamethasone—ankylosing spondylitis	0.00161	0.0119	CcSEcCtD
Tenofovir—NME1—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.0016	0.25	CbGdCrCtD
Tenofovir—NME1—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.0016	0.25	CbGdCrCtD
Tenofovir—NME1—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.00156	0.245	CbGdCrCtD
Tenofovir—Glycosuria—Triamcinolone—ankylosing spondylitis	0.00155	0.0115	CcSEcCtD
Tenofovir—Glycosuria—Methylprednisolone—ankylosing spondylitis	0.00154	0.0115	CcSEcCtD
Tenofovir—Fracture—Methotrexate—ankylosing spondylitis	0.00142	0.0106	CcSEcCtD
Tenofovir—Multiple fractures—Methotrexate—ankylosing spondylitis	0.00142	0.0106	CcSEcCtD
Tenofovir—Myopathy—Prednisone—ankylosing spondylitis	0.00141	0.0105	CcSEcCtD
Tenofovir—Glycosuria—Dexamethasone—ankylosing spondylitis	0.0014	0.0104	CcSEcCtD
Tenofovir—Glycosuria—Betamethasone—ankylosing spondylitis	0.0014	0.0104	CcSEcCtD
Tenofovir—Hepatomegaly—Prednisone—ankylosing spondylitis	0.0014	0.0104	CcSEcCtD
Tenofovir—Glycosuria—Prednisone—ankylosing spondylitis	0.00122	0.00909	CcSEcCtD
Tenofovir—Proteinuria—Methotrexate—ankylosing spondylitis	0.000941	0.00701	CcSEcCtD
Tenofovir—Protein urine present—Methotrexate—ankylosing spondylitis	0.000928	0.00691	CcSEcCtD
Tenofovir—Muscular weakness—Prednisolone—ankylosing spondylitis	0.000872	0.00649	CcSEcCtD
Tenofovir—Pancreatitis—Prednisolone—ankylosing spondylitis	0.000838	0.00623	CcSEcCtD
Tenofovir—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.000802	0.00597	CcSEcCtD
Tenofovir—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.0008	0.00595	CcSEcCtD
Tenofovir—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.000771	0.00573	CcSEcCtD
Tenofovir—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.000769	0.00572	CcSEcCtD
Tenofovir—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.000751	0.00559	CcSEcCtD
Tenofovir—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.000751	0.00559	CcSEcCtD
Tenofovir—Urine output increased—Methotrexate—ankylosing spondylitis	0.000748	0.00556	CcSEcCtD
Tenofovir—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000747	0.00556	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00073	0.00543	CcSEcCtD
Tenofovir—Muscular weakness—Betamethasone—ankylosing spondylitis	0.000728	0.00541	CcSEcCtD
Tenofovir—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.000728	0.00541	CcSEcCtD
Tenofovir—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000699	0.0052	CcSEcCtD
Tenofovir—Infestation—Methylprednisolone—ankylosing spondylitis	0.000699	0.0052	CcSEcCtD
Tenofovir—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.000687	0.00511	CcSEcCtD
Tenofovir—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.000685	0.0051	CcSEcCtD
Tenofovir—Polyuria—Methotrexate—ankylosing spondylitis	0.000684	0.00509	CcSEcCtD
Tenofovir—Sweating—Methylprednisolone—ankylosing spondylitis	0.00067	0.00499	CcSEcCtD
Tenofovir—Hypokalaemia—Prednisone—ankylosing spondylitis	0.000654	0.00487	CcSEcCtD
Tenofovir—Renal failure acute—Methotrexate—ankylosing spondylitis	0.00065	0.00484	CcSEcCtD
Tenofovir—Weight decreased—Betamethasone—ankylosing spondylitis	0.000645	0.0048	CcSEcCtD
Tenofovir—Weight decreased—Dexamethasone—ankylosing spondylitis	0.000645	0.0048	CcSEcCtD
Tenofovir—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000643	0.00479	CcSEcCtD
Tenofovir—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000643	0.00479	CcSEcCtD
Tenofovir—Muscular weakness—Prednisone—ankylosing spondylitis	0.000634	0.00472	CcSEcCtD
Tenofovir—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000623	0.00464	CcSEcCtD
Tenofovir—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000623	0.00464	CcSEcCtD
Tenofovir—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000617	0.00459	CcSEcCtD
Tenofovir—Pancreatitis—Prednisone—ankylosing spondylitis	0.000609	0.00453	CcSEcCtD
Tenofovir—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000567	0.00422	CcSEcCtD
Tenofovir—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000566	0.00421	CcSEcCtD
Tenofovir—Weight decreased—Prednisone—ankylosing spondylitis	0.000562	0.00418	CcSEcCtD
Tenofovir—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00056	0.00417	CcSEcCtD
Tenofovir—Depression—Prednisone—ankylosing spondylitis	0.000552	0.00411	CcSEcCtD
Tenofovir—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00055	0.00409	CcSEcCtD
Tenofovir—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000546	0.00407	CcSEcCtD
Tenofovir—Angioedema—Prednisolone—ankylosing spondylitis	0.000544	0.00405	CcSEcCtD
Tenofovir—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000543	0.00404	CcSEcCtD
Tenofovir—Back pain—Triamcinolone—ankylosing spondylitis	0.00053	0.00394	CcSEcCtD
Tenofovir—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000509	0.00379	CcSEcCtD
Tenofovir—Angioedema—Triamcinolone—ankylosing spondylitis	0.0005	0.00372	CcSEcCtD
Tenofovir—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000499	0.00371	CcSEcCtD
Tenofovir—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000488	0.00363	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000482	0.00359	CcSEcCtD
Tenofovir—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00047	0.0035	CcSEcCtD
Tenofovir—Myalgia—Triamcinolone—ankylosing spondylitis	0.000466	0.00347	CcSEcCtD
Tenofovir—Pneumonia—Methotrexate—ankylosing spondylitis	0.000465	0.00346	CcSEcCtD
Tenofovir—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000465	0.00346	CcSEcCtD
Tenofovir—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000465	0.00346	CcSEcCtD
Tenofovir—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000464	0.00345	CcSEcCtD
Tenofovir—Infestation—Methotrexate—ankylosing spondylitis	0.000463	0.00344	CcSEcCtD
Tenofovir—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000463	0.00344	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000462	0.00344	CcSEcCtD
Tenofovir—Depression—Methotrexate—ankylosing spondylitis	0.000461	0.00343	CcSEcCtD
Tenofovir—Renal failure—Methotrexate—ankylosing spondylitis	0.000455	0.00338	CcSEcCtD
Tenofovir—Angioedema—Dexamethasone—ankylosing spondylitis	0.000454	0.00338	CcSEcCtD
Tenofovir—Angioedema—Betamethasone—ankylosing spondylitis	0.000454	0.00338	CcSEcCtD
Tenofovir—Immune system disorder—Prednisone—ankylosing spondylitis	0.000449	0.00334	CcSEcCtD
Tenofovir—Sweating—Methotrexate—ankylosing spondylitis	0.000444	0.0033	CcSEcCtD
Tenofovir—Haematuria—Methotrexate—ankylosing spondylitis	0.000441	0.00328	CcSEcCtD
Tenofovir—Insomnia—Prednisolone—ankylosing spondylitis	0.00044	0.00327	CcSEcCtD
Tenofovir—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000438	0.00326	CcSEcCtD
Tenofovir—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000437	0.00325	CcSEcCtD
Tenofovir—Mental disorder—Prednisone—ankylosing spondylitis	0.000435	0.00324	CcSEcCtD
Tenofovir—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000433	0.00322	CcSEcCtD
Tenofovir—Malnutrition—Prednisone—ankylosing spondylitis	0.000433	0.00322	CcSEcCtD
Tenofovir—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000432	0.00321	CcSEcCtD
Tenofovir—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000431	0.00321	CcSEcCtD
Tenofovir—Myalgia—Dexamethasone—ankylosing spondylitis	0.000423	0.00315	CcSEcCtD
Tenofovir—Myalgia—Betamethasone—ankylosing spondylitis	0.000423	0.00315	CcSEcCtD
Tenofovir—Anxiety—Dexamethasone—ankylosing spondylitis	0.000422	0.00314	CcSEcCtD
Tenofovir—Anxiety—Betamethasone—ankylosing spondylitis	0.000422	0.00314	CcSEcCtD
Tenofovir—Pain—Prednisolone—ankylosing spondylitis	0.000416	0.00309	CcSEcCtD
Tenofovir—Hepatitis—Methotrexate—ankylosing spondylitis	0.000415	0.00309	CcSEcCtD
Tenofovir—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00041	0.00305	CcSEcCtD
Tenofovir—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000407	0.00303	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000407	0.00303	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000406	0.00302	CcSEcCtD
Tenofovir—Insomnia—Triamcinolone—ankylosing spondylitis	0.000404	0.00301	CcSEcCtD
Tenofovir—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000403	0.003	CcSEcCtD
Tenofovir—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000398	0.00296	CcSEcCtD
Tenofovir—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000398	0.00296	CcSEcCtD
Tenofovir—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000398	0.00296	CcSEcCtD
Tenofovir—Angioedema—Prednisone—ankylosing spondylitis	0.000395	0.00294	CcSEcCtD
Tenofovir—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000393	0.00293	CcSEcCtD
Tenofovir—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000393	0.00292	CcSEcCtD
Tenofovir—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000392	0.00292	CcSEcCtD
Tenofovir—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000392	0.00292	CcSEcCtD
Tenofovir—Anorexia—Dexamethasone—ankylosing spondylitis	0.000387	0.00288	CcSEcCtD
Tenofovir—Anorexia—Betamethasone—ankylosing spondylitis	0.000387	0.00288	CcSEcCtD
Tenofovir—Fatigue—Triamcinolone—ankylosing spondylitis	0.000385	0.00287	CcSEcCtD
Tenofovir—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000384	0.00286	CcSEcCtD
Tenofovir—Pain—Triamcinolone—ankylosing spondylitis	0.000382	0.00284	CcSEcCtD
Tenofovir—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000375	0.00279	CcSEcCtD
Tenofovir—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000374	0.00279	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000369	0.00275	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000369	0.00275	CcSEcCtD
Tenofovir—Arthralgia—Prednisone—ankylosing spondylitis	0.000368	0.00274	CcSEcCtD
Tenofovir—Myalgia—Prednisone—ankylosing spondylitis	0.000368	0.00274	CcSEcCtD
Tenofovir—Anxiety—Prednisone—ankylosing spondylitis	0.000367	0.00273	CcSEcCtD
Tenofovir—Insomnia—Dexamethasone—ankylosing spondylitis	0.000367	0.00273	CcSEcCtD
Tenofovir—Insomnia—Betamethasone—ankylosing spondylitis	0.000367	0.00273	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000366	0.00272	CcSEcCtD
Tenofovir—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000365	0.00271	CcSEcCtD
Tenofovir—Mental disorder—Methotrexate—ankylosing spondylitis	0.000364	0.00271	CcSEcCtD
Tenofovir—Malnutrition—Methotrexate—ankylosing spondylitis	0.000362	0.00269	CcSEcCtD
Tenofovir—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000358	0.00266	CcSEcCtD
Tenofovir—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000357	0.00266	CcSEcCtD
Tenofovir—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000357	0.00266	CcSEcCtD
Tenofovir—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000353	0.00263	CcSEcCtD
Tenofovir—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000353	0.00262	CcSEcCtD
Tenofovir—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000353	0.00262	CcSEcCtD
Tenofovir—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000353	0.00262	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00035	0.0026	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00035	0.0026	CcSEcCtD
Tenofovir—Back pain—Methotrexate—ankylosing spondylitis	0.00035	0.0026	CcSEcCtD
Tenofovir—Fatigue—Betamethasone—ankylosing spondylitis	0.00035	0.0026	CcSEcCtD
Tenofovir—Fatigue—Dexamethasone—ankylosing spondylitis	0.00035	0.0026	CcSEcCtD
Tenofovir—Pain—Betamethasone—ankylosing spondylitis	0.000347	0.00258	CcSEcCtD
Tenofovir—Pain—Dexamethasone—ankylosing spondylitis	0.000347	0.00258	CcSEcCtD
Tenofovir—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000346	0.00258	CcSEcCtD
Tenofovir—Skin disorder—Prednisone—ankylosing spondylitis	0.000343	0.00255	CcSEcCtD
Tenofovir—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000341	0.00254	CcSEcCtD
Tenofovir—Anorexia—Prednisone—ankylosing spondylitis	0.000337	0.0025	CcSEcCtD
Tenofovir—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000332	0.00247	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000332	0.00247	CcSEcCtD
Tenofovir—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000329	0.00245	CcSEcCtD
Tenofovir—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000329	0.00244	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000322	0.00239	CcSEcCtD
Tenofovir—Dizziness—Prednisolone—ankylosing spondylitis	0.000321	0.00239	CcSEcCtD
Tenofovir—Asthenia—Triamcinolone—ankylosing spondylitis	0.000321	0.00239	CcSEcCtD
Tenofovir—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000321	0.00239	CcSEcCtD
Tenofovir—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000321	0.00239	CcSEcCtD
Tenofovir—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000321	0.00239	CcSEcCtD
Tenofovir—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000321	0.00239	CcSEcCtD
Tenofovir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00032	0.00238	CcSEcCtD
Tenofovir—Insomnia—Prednisone—ankylosing spondylitis	0.000319	0.00238	CcSEcCtD
Tenofovir—Pruritus—Triamcinolone—ankylosing spondylitis	0.000316	0.00235	CcSEcCtD
Tenofovir—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000315	0.00235	CcSEcCtD
Tenofovir—Dyspepsia—Prednisone—ankylosing spondylitis	0.000311	0.00231	CcSEcCtD
Tenofovir—Myalgia—Methotrexate—ankylosing spondylitis	0.000308	0.00229	CcSEcCtD
Tenofovir—Chest pain—Methotrexate—ankylosing spondylitis	0.000308	0.00229	CcSEcCtD
Tenofovir—Arthralgia—Methotrexate—ankylosing spondylitis	0.000308	0.00229	CcSEcCtD
Tenofovir—Decreased appetite—Prednisone—ankylosing spondylitis	0.000307	0.00228	CcSEcCtD
Tenofovir—Rash—Prednisolone—ankylosing spondylitis	0.000306	0.00228	CcSEcCtD
Tenofovir—Dermatitis—Prednisolone—ankylosing spondylitis	0.000306	0.00228	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000306	0.00227	CcSEcCtD
Tenofovir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000305	0.00227	CcSEcCtD
Tenofovir—Fatigue—Prednisone—ankylosing spondylitis	0.000304	0.00227	CcSEcCtD
Tenofovir—Headache—Prednisolone—ankylosing spondylitis	0.000304	0.00227	CcSEcCtD
Tenofovir—Dizziness—Triamcinolone—ankylosing spondylitis	0.000296	0.0022	CcSEcCtD
Tenofovir—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000295	0.00219	CcSEcCtD
Tenofovir—Asthenia—Betamethasone—ankylosing spondylitis	0.000291	0.00216	CcSEcCtD
Tenofovir—Asthenia—Dexamethasone—ankylosing spondylitis	0.000291	0.00216	CcSEcCtD
Tenofovir—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000289	0.00215	CcSEcCtD
Tenofovir—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000289	0.00215	CcSEcCtD
Tenofovir—Nausea—Prednisolone—ankylosing spondylitis	0.000289	0.00215	CcSEcCtD
Tenofovir—Pruritus—Betamethasone—ankylosing spondylitis	0.000287	0.00213	CcSEcCtD
Tenofovir—Pruritus—Dexamethasone—ankylosing spondylitis	0.000287	0.00213	CcSEcCtD
Tenofovir—Skin disorder—Methotrexate—ankylosing spondylitis	0.000287	0.00213	CcSEcCtD
Tenofovir—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000285	0.00212	CcSEcCtD
Tenofovir—Vomiting—Triamcinolone—ankylosing spondylitis	0.000284	0.00211	CcSEcCtD
Tenofovir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000284	0.00211	CcSEcCtD
Tenofovir—Rash—Triamcinolone—ankylosing spondylitis	0.000282	0.0021	CcSEcCtD
Tenofovir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000282	0.00209	CcSEcCtD
Tenofovir—Anorexia—Methotrexate—ankylosing spondylitis	0.000281	0.00209	CcSEcCtD
Tenofovir—Rash—Methylprednisolone—ankylosing spondylitis	0.000281	0.00209	CcSEcCtD
Tenofovir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000281	0.00209	CcSEcCtD
Tenofovir—Headache—Triamcinolone—ankylosing spondylitis	0.00028	0.00208	CcSEcCtD
Tenofovir—Headache—Methylprednisolone—ankylosing spondylitis	0.000279	0.00208	CcSEcCtD
Tenofovir—Body temperature increased—Prednisone—ankylosing spondylitis	0.000279	0.00208	CcSEcCtD
Tenofovir—Abdominal pain—Prednisone—ankylosing spondylitis	0.000279	0.00208	CcSEcCtD
Tenofovir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000277	0.00206	CcSEcCtD
Tenofovir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000277	0.00206	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000269	0.002	CcSEcCtD
Tenofovir—Dizziness—Betamethasone—ankylosing spondylitis	0.000268	0.002	CcSEcCtD
Tenofovir—Dizziness—Dexamethasone—ankylosing spondylitis	0.000268	0.002	CcSEcCtD
Tenofovir—Insomnia—Methotrexate—ankylosing spondylitis	0.000267	0.00199	CcSEcCtD
Tenofovir—Nausea—Triamcinolone—ankylosing spondylitis	0.000265	0.00198	CcSEcCtD
Tenofovir—Nausea—Methylprednisolone—ankylosing spondylitis	0.000265	0.00197	CcSEcCtD
Tenofovir—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000263	0.00196	CcSEcCtD
Tenofovir—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00026	0.00194	CcSEcCtD
Tenofovir—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00026	0.00193	CcSEcCtD
Tenofovir—Vomiting—Dexamethasone—ankylosing spondylitis	0.000258	0.00192	CcSEcCtD
Tenofovir—Vomiting—Betamethasone—ankylosing spondylitis	0.000258	0.00192	CcSEcCtD
Tenofovir—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000257	0.00191	CcSEcCtD
Tenofovir—Rash—Dexamethasone—ankylosing spondylitis	0.000256	0.0019	CcSEcCtD
Tenofovir—Rash—Betamethasone—ankylosing spondylitis	0.000256	0.0019	CcSEcCtD
Tenofovir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000255	0.0019	CcSEcCtD
Tenofovir—Dermatitis—Betamethasone—ankylosing spondylitis	0.000255	0.0019	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000255	0.0019	CcSEcCtD
Tenofovir—Fatigue—Methotrexate—ankylosing spondylitis	0.000254	0.00189	CcSEcCtD
Tenofovir—Headache—Betamethasone—ankylosing spondylitis	0.000254	0.00189	CcSEcCtD
Tenofovir—Headache—Dexamethasone—ankylosing spondylitis	0.000254	0.00189	CcSEcCtD
Tenofovir—Asthenia—Prednisone—ankylosing spondylitis	0.000253	0.00189	CcSEcCtD
Tenofovir—Pain—Methotrexate—ankylosing spondylitis	0.000252	0.00188	CcSEcCtD
Tenofovir—Pruritus—Prednisone—ankylosing spondylitis	0.00025	0.00186	CcSEcCtD
Tenofovir—Diarrhoea—Prednisone—ankylosing spondylitis	0.000242	0.0018	CcSEcCtD
Tenofovir—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000241	0.0018	CcSEcCtD
Tenofovir—Nausea—Dexamethasone—ankylosing spondylitis	0.000241	0.00179	CcSEcCtD
Tenofovir—Nausea—Betamethasone—ankylosing spondylitis	0.000241	0.00179	CcSEcCtD
Tenofovir—Dizziness—Prednisone—ankylosing spondylitis	0.000234	0.00174	CcSEcCtD
Tenofovir—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000233	0.00174	CcSEcCtD
Tenofovir—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000233	0.00174	CcSEcCtD
Tenofovir—Vomiting—Prednisone—ankylosing spondylitis	0.000225	0.00167	CcSEcCtD
Tenofovir—Rash—Prednisone—ankylosing spondylitis	0.000223	0.00166	CcSEcCtD
Tenofovir—Dermatitis—Prednisone—ankylosing spondylitis	0.000222	0.00166	CcSEcCtD
Tenofovir—Headache—Prednisone—ankylosing spondylitis	0.000221	0.00165	CcSEcCtD
Tenofovir—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000217	0.00162	CcSEcCtD
Tenofovir—Asthenia—Methotrexate—ankylosing spondylitis	0.000212	0.00158	CcSEcCtD
Tenofovir—Nausea—Prednisone—ankylosing spondylitis	0.00021	0.00156	CcSEcCtD
Tenofovir—Pruritus—Methotrexate—ankylosing spondylitis	0.000209	0.00155	CcSEcCtD
Tenofovir—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000202	0.0015	CcSEcCtD
Tenofovir—Dizziness—Methotrexate—ankylosing spondylitis	0.000195	0.00145	CcSEcCtD
Tenofovir—Vomiting—Methotrexate—ankylosing spondylitis	0.000188	0.0014	CcSEcCtD
Tenofovir—Rash—Methotrexate—ankylosing spondylitis	0.000186	0.00138	CcSEcCtD
Tenofovir—Dermatitis—Methotrexate—ankylosing spondylitis	0.000186	0.00138	CcSEcCtD
Tenofovir—Headache—Methotrexate—ankylosing spondylitis	0.000185	0.00138	CcSEcCtD
Tenofovir—Nausea—Methotrexate—ankylosing spondylitis	0.000175	0.0013	CcSEcCtD
